Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Guishan, Taoyuan, Taiwan.
Hernia. 2021 Oct;25(5):1317-1324. doi: 10.1007/s10029-020-02364-7. Epub 2021 Feb 6.
Occult inguinal hernias (IH) predispose peritoneal dialysis (PD) patients to the symptomatic IH formation after starting PD, which may cause complications. We conducted a retrospective study to assess the benefit/risk profile of routine laparoscopic examination for occult IH (RLEOH) with a synchronous repair in patients receiving PD catheter placement.
432 patients were enrolled in this study. Patients with an internal hernia sac at all sizes were deemed to have occult IH. We retrospectively reviewed data including demographic characteristics and operative details. We also measured incidence rates of symptomatic IH, metachronous IH repair, and catheter survival over a follow-up period after starting PD.
These patients were classified into the RLEOH group (n = 365) and the non-RLEOH group (n = 67). The RLEOH group was subdivided into occult IH with a synchronous repair (n = 17; the subgroup A), no occult IH (n = 339; the subgroup B), and occult IH without a synchronous repair (n = 9; the subgroup C). The incidence rates of symptomatic IH developed after staring PD in subgroups A, B, and C were 0, 5.6, and 22.2%, respectively, whereas that in the non-RLEOH group was 13.4%. The RLEOH group had a reduced hazard ratio for metachronous IH repair compared with the non-RLEOH group (HR = 0.426; 95% CI 0.195-0.930, p = 0.032). None of our patients suffered from herniorrhaphy-related complications.
RLEOH with a synchronous repair during PD catheter insertion confers clinical benefits in reducing the risk of developing IH after starting PD and the need for a metachronous repair. This is a safe and reasonable approach.
隐匿性腹股沟疝(IH)使腹膜透析(PD)患者在开始 PD 后易发生症状性 IH 形成,这可能导致并发症。我们进行了一项回顾性研究,以评估在 PD 导管放置时对接受治疗的患者进行常规腹腔镜检查隐匿性 IH(RLEOH)并同步修复的获益/风险状况。
本研究共纳入 432 例患者。所有大小的疝囊内疝均被认为患有隐匿性 IH。我们回顾性分析了包括人口统计学特征和手术细节在内的数据。我们还测量了在开始 PD 后的随访期间症状性 IH、迟发性 IH 修复和导管存活率的发生率。
这些患者被分为 RLEOH 组(n = 365)和非 RLEOH 组(n = 67)。RLEOH 组进一步分为隐匿性 IH 伴同步修复组(n = 17;亚组 A)、无隐匿性 IH 组(n = 339;亚组 B)和隐匿性 IH 无同步修复组(n = 9;亚组 C)。亚组 A、B 和 C 中在开始 PD 后出现症状性 IH 的发生率分别为 0、5.6%和 22.2%,而非 RLEOH 组的发生率为 13.4%。与非 RLEOH 组相比,RLEOH 组迟发性 IH 修复的风险比降低(HR = 0.426;95%CI 0.195-0.930,p = 0.032)。我们的患者均未出现疝修补相关并发症。
在 PD 导管插入时进行 RLEOH 并同步修复可降低开始 PD 后 IH 发展的风险和需要迟发性修复的风险,从而带来临床获益。这是一种安全且合理的方法。